Stratton M, Rahman N. The emerging landscape of breast cancer susceptibility. Nat Genet. 2008;40(1):17–22.
Article CAS PubMed Google Scholar
Tai YC, Domchek S, Parmigiani G, Chen S. Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2007;99(23):1811.
Article CAS PubMed Google Scholar
Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, et al. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N Engl J Med. 2021;384(25):2394–405.
Article CAS PubMed PubMed Central Google Scholar
Litton JK, Rugo HS, Ettl J, Hurvitz SA, Gonçalves A, Lee KH, et al. Talazoparib in patients with advanced breast cancer and a germline BRCA mutation. N Engl J Med. 2018;379(8):753–63.
Article CAS PubMed Google Scholar
Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2017;377(6):523–33.
Article CAS PubMed Google Scholar
Armstrong N, Ryder S, Forbes C, Ross J, Quek R. A systematic review of the international prevalence of BRCA mutation in breast cancer. Clin Epidemiol. 2019;11:543–61.
Article PubMed PubMed Central Google Scholar
Ferla R, Calò V, Cascio S, Rinaldi G, Badalamenti G, Carreca I, et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol. 2007;18(Suppl 6):vi93–8.
Azim HA, Ibrahim AS. Breast cancer in Egypt, China and Chinese: statistics and beyond. J Thorac Dis. 2014;6(7):864.
PubMed PubMed Central Google Scholar
Najjar H, Easson A. Age at diagnosis of breast cancer in Arab nations. Int J Surg. 2010;8(6):448–52.
Ibrahim SS, Hafez EE, Hashishe MM. Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection. J Exp Clin Cancer Res. 2010;29:82.
Article PubMed PubMed Central Google Scholar
Bensam M, Hafez E, Awad DMES, Balbaa M. Detection of new point mutations of BRCA1 and BRCA2 in breast cancer patients. Biochem Genet. 2014;52(1–2):15–28.
Article CAS PubMed Google Scholar
Hussien YM, Gharib AF, Ibrahim HM, Abdel-Ghany ME, Elsawy WH. Analysis of BRCA1 and BRCA2 mutations in eastern Egyptian breast cancer patients. Bull Egypt Soc Physiol Sci. 2011;31(1):107.
Abdel-Mohsen M, Ahmed O, El-Kerm Y. BRCA1 gene mutations and influence of chemotherapy on autophagy and apoptotic mechanisms in Egyptian breast cancer patients. Asian Pac J Cancer Prev. 2016;17(3):1285–92.
Kemp Z, Turnbull A, Yost S, Seal S, Mahamdallie S, Poyastro-Pearson E, et al. Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer. JAMA Netw Open. 2019;2(5): e194428.
Article PubMed PubMed Central Google Scholar
Trujillano D, Weiss MER, Schneider J, Köster J, Papachristos EB, Saviouk V, et al. Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer. J Mol Diagn. 2015;17(2):162–70.
Article CAS PubMed Google Scholar
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Br Med J. 2015;2(349):g7647–g7647.
Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Heal. 2014;72(1):1–10.
El-Debaky F, Azab N, Alhusseini N, Eliwa S, Musalam H. Breast Cancer Gene 1 (Brca 1) mutation in female patients with or without family history in Qalubia Governorate. J Am Sci. 2011;7(2):82–93.
Mahmoud N, Moustafa A, Mahrous H, El-Gezeery A, Mahmoud H, Abd E-M. BRCA1 (185delAG) mutation among Egyptian breast cancer female patients. J High Inst Public Heal. 2008;38(2):409–24.
AbdelHamid S, Zekri A, AbdelAziz H, El-Mesallamy H. BRCA1 and BRCA2 truncating mutations and variants of unknown significance in Egyptian female breast cancer patients. Clin Chim Acta. 2021;512:66–73.
Article CAS PubMed Google Scholar
Abou-El-Naga A, Shaban A, Ghazy H, Elsaid A, Elshazli R, Settin A. Frequency of BRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) mutations in Egyptian women with breast cancer compared to healthy controls. Meta Gene. 2018;15:35–41.
Eid OM, El Ghoroury EA, Eid MM, Mahrous RM, Abdelhamid MI, Aboafya ZI, et al. Evaluation of BRCA1 large genomic rearrangements in group of Egyptian Female Breast cancer patients using MLPA. Gulf J Oncol. 2017;1:64.
Mogahed S, Hamed Y, Moursy Y, Saied M. Analysis of heterozygous BRCA1 5382ins founder mutation in a cohort of Egyptian breast cancer female patients using pyrosequencing technique. Asian Pac J Cancer Prev. 2020;21(2):431–8.
Article CAS PubMed Central Google Scholar
Abdel-Aziz T, Azab N, Emara NM, Odah MM, El-Deen I. Study of BRCA2 gene mutations in Egyptian females with breast cancer. Int J Innov Res Sci Eng Technol. 2007;3297(2):14.
Hagag E, Shwaireb M, Coffa J, El WA. Screening for BRCA1 large genomic rearrangements in female Egyptian hereditary breast cancer patients. East Mediterr Heal J. 2013;19(3):256.
Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–52.
Article CAS PubMed Google Scholar
Ellison G, Wallace A, Kohlmann A, Patton S. A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories. Br J Cancer. 2017;117(5):710.
Article CAS PubMed PubMed Central Google Scholar
Frayling IM. Methods of molecular analysis: mutation detection in solid tumours. Mol Pathol. 2002;55(2):73.
Article CAS PubMed PubMed Central Google Scholar
El-Deiry W, Goldberg R, Lenz H, Shields A, Gibney G, Tan A, et al. The current state of molecular testing in the treatment of patients with solid tumors, 2019. CA Cancer J Clin. 2019;69(4):305–43.
Article PubMed PubMed Central Google Scholar
Kim Y, Soliman A, Cui J, Ramadan M, Hablas A, Abouelhoda M, et al. Unique features of germline variation in five Egyptian familial breast cancer families revealed by exome sequencing. PLoS ONE. 2017;12(1):e0167581.
Article PubMed PubMed Central Google Scholar
Pagani L, Schiffels S, Gurdasani D, Danecek P, Scally A, Chen Y, et al. Tracing the route of modern humans out of Africa by using 225 human genome sequences from Ethiopians and Egyptians. Am J Hum Genet. 2015;96(6):986.
Article CAS PubMed PubMed Central Google Scholar
Nassar A, Zekri ARN, Kamel MM, Elberry MH, Lotfy MM, Seadawy MG, et al. Frequency of pathogenic germline mutations in early and late onset familial breast cancer patients using multi-gene panel sequencing: an Egyptian study. Genes (Basel). 2022;14(1):106.
El SNS, Zgheib NK, Assi HA, Khoury KE, Bidet Y, Jaber SM, et al. BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer. Oncologist. 2015;20(4):357.
Abdel-Razeq H, Al-Omari A, Zahran F, Arun B. Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan. BMC Cancer. 2018;18(1):1–1.
Abdulrashid K, AlHussaini N, Ahmed W, Thalib L. Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis. BMC Cancer. 2019;19(1):1–12.
Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM, et al. Contralateral prophylactic mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: data on CPM outcomes and risks. Ann Surg Oncol. 2016;23(10):3100–5.
Article PubMed PubMed Central Google Scholar
Berek JS, Chalas E, Edelson M, Moore DH, Burke WM, Cliby WA, et al. Prophylactic and risk-reducing bilateral salpingo-oophorectomy. Obstet Gynecol. 2010;116(3):733–43.
Comments (0)